Cincinnati Children's is conducting a research study, also known as a clinical study or trial, to learn if a new investigational COVID-19 vaccine is safe, and may prevent serious illness or keep the virus from spreading to others.
Adults 18 to 64 years of age who are generally healthy or with stable chronic medical conditions and:
The study includes at least 8 planned study visits and one phone contact over 6 - 7 months. You may be requested to come into our study center for visits outside of your scheduled visits if you have any symptoms of COVID-19. Here are some of the things that will happen in this study:
You may or may not personally benefit from your participation in this trial. However, by taking part, you will help to provide new scientific information that will contribute to the development of COVID-19 vaccines.
As with any vaccine, you may have side effects. Possible risks and discomforts will be discussed with you prior to the start of the study.
Participants will receive up to $1,000 for time and effort to complete the study.
The Vaccine Research Center at Cincinnati Children’s
https://redcap.link/GyldenCovid
513-636-7699
VaccineResearch@cchmc.org
Cincinnati Children’s Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039
Rebecca Brady MD
Infectious Diseases
A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required by U.S. Law. This Web site will not include any information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. NCT07183709.